Debut Plus

₹370.4

▼ -1.64 -0.44%

17 Jul 2026

NSE Listed

Gujarat Themis Biosyn Ltd. (GUJTHEM)

Volume: 56,597Avg Vol 1W: 95,175.8Avg Vol 1M: 98,736.352W Range:₹225.05₹479
NSE BSE www.gtbl.in
Key Ratios
Checked 1h ago
Market Cap₹4,036 Cr
Current Price₹370.4
Previous Close₹372.04
High / Low (52w)₹479 / ₹225.05
Volume56,597
Avg Vol (1W)95,175.8
Avg Vol (1M)98,736.3
Stock P/E370.4
Book Value₹26.41
Dividend Yield18%
ROE16.22%
ROA9.27%
Revenue (TTM)₹152 Cr
Revenue Growth17.2%
Profit Margin28.14%
Total Debt₹162 Cr
Shares Outstanding11 Cr
Face Value₹1
EPS (TTM)₹4.28
P/B14.04
Debt / Equity0.07
50 DMA₹386.51
200 DMA₹371.14
Day change-0.44%
Price Chart
₹370.4▼ 0.23% · 1Y
₹470₹22796.6L
2025-07-17
2026-07-16

20-day avg volume: 99K shares

Pros
  • Healthy return on equity of 16.2%.
  • Pays a dividend yield of 18.0%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 370.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹39 Cr₹35 Cr₹40 Cr₹38 Cr₹36 Cr₹42 Cr₹43 Cr₹44 Cr
EBITDA₹18 Cr₹14 Cr₹18 Cr₹16 Cr₹12 Cr₹19 Cr₹18 Cr₹16 Cr
Net Profit₹13 Cr₹11 Cr₹13 Cr₹12 Cr₹9 Cr₹14 Cr₹12 Cr₹11 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹39 Cr₹43 Cr₹87 Cr₹94 Cr₹119 Cr₹155 Cr₹174 Cr₹152 Cr
EBITDA₹5 Cr₹8 Cr₹32 Cr₹42 Cr₹60 Cr₹78 Cr₹80 Cr₹66 Cr
Net Profit₹4 Cr₹6 Cr₹24 Cr₹30 Cr₹44 Cr₹58 Cr₹59 Cr₹49 Cr
EPS2.664.4116.320.7730.0339.940.724.48
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹33 Cr₹64 Cr₹88 Cr₹123 Cr₹166 Cr₹221 Cr₹301 Cr₹503 Cr
Total Liabilities₹14 Cr₹22 Cr₹18 Cr₹19 Cr₹17 Cr₹20 Cr₹53 Cr₹216 Cr
Equity₹19 Cr₹42 Cr₹70 Cr₹103 Cr₹149 Cr₹201 Cr₹248 Cr₹288 Cr
Total Debt————₹41,91,000 Cr₹3 Cr₹30 Cr₹162 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹8 Cr₹21 Cr₹55 Cr₹39 Cr₹64 Cr₹91 Cr₹49 Cr
Investing₹-3 Cr₹-2 Cr₹-30 Cr₹-20 Cr₹-55 Cr₹-112 Cr₹-172 Cr
Financing₹2 Cr₹-5 Cr₹-14 Cr₹-13 Cr₹-9 Cr₹26 Cr₹115 Cr
Free Cash Flow₹8 Cr₹21 Cr₹55 Cr₹16 Cr₹-10 Cr₹-25 Cr₹-124 Cr
Shareholding
Promoter 70.86% Institutions 2.97% Public 26.16%
About Gujarat Themis Biosyn Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India and Japan. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.

www.gtbl.in ↗
Efficiency & Working Capital
ROCE14.5%
Interest Coverage183.1
Dividend Payout—
Debtor Days76 d
Inventory Days12 d
Payable Days35 d
Cash Conversion Cycle52 d
Working Capital Days88 d
Shareholding Details

As of 2026-03-31

Promoter70.9%
FII1.8%
DII1.2%
Institutions3%
Public26.2%
Promoter Pledge5.4%
No. of Shareholders26,886
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Feb 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters75%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%
FIIs0%0.9%1%1.4%1.5%1.4%1.5%1.9%2.5%3%2%1.8%
DIIs0%0%0.8%1.2%1.2%1.2%1.2%1.2%1.2%1.2%1.2%1.2%
Public25%28.2%27.3%26.5%26.5%26.5%26.5%26%25.5%25%26%26.2%
Promoter Pledge0%3.3%3.3%3.3%3.3%3.3%3.3%3.3%3.3%3.3%4.5%5.4%
No. of Shareholders19,84628,65529,57630,28031,27130,93430,43630,67328,94528,31927,32526,886
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Pharmaceutical Business Group [india] LtdShareholding of Promoter and Promoter Group47%5.12 Cr
Themis Medicare LimitedShareholding of Promoter and Promoter Group23.2%2.53 Cr
Quant Mutual Fund - Quant Manufacturing FundPublic Shareholding1.2%12,54,000
Ayushmat LtdPublic Shareholding1.1%12,20,000
Vividhmargi Trust (trustees - Dinesh Shantilal Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel AndShareholding of Promoter and Promoter Group0.6%6,60,302
Anay Rupen ChoksiShareholding of Promoter and Promoter Group0%22,852
Nysha Rupen ChoksiShareholding of Promoter and Promoter Group0%22,852
Jayshree D PatelShareholding of Promoter and Promoter Group0%10
Sachin Dinesh PatelShareholding of Promoter and Promoter Group0%10
Reena S PatelShareholding of Promoter and Promoter Group0%10
Dinesh Shantilal PatelShareholding of Promoter and Promoter Group0%10
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Jayshree D Patel00%2026-03-31
Sachin Dinesh Patel00%2026-03-31
Reena S Patel00%2026-03-31
Dinesh Shantilal Patel00%2026-03-31
Anay Rupen Choksi00%2026-03-31
Nysha Rupen Choksi00%2026-03-31
Pharmaceutical Business Group [india] Ltd25,50,0005%2026-03-31
Themis Medicare Limited16,50,0006.5%2026-03-31
Vividhmargi Trust (trustees - Dinesh Shantilal Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel And00%2026-03-31
Quant Mutual Fund - Quant Manufacturing Fund00%2026-03-31
Ayushmat Ltd00%2026-03-31
Jayshree D Patel00%2025-12-31
Board of Directors
NameDesignationYear
Dinesh S PatelChairman & Non Executive Dir.2025
Sachin D PatelManaging Director2025
Kirandeep MadanIndependent Non Exe. Director2025
Hitesh Dharmasinh GajariaIndependent Non Exe. Director2025
K G AnanthakrishnanIndependent Non Exe. Director2025
NIHAR AJAY PARIKHIndependent Director2025
Rajneesh AnandAdditional Director2025
Segments — Product
SegmentRevenueShare
Bulk Drugs for its own & Job Work₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹151 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1251111
Corporate Actions
TypeDateValueRemark
dividend2025-09-04₹0.67 (67%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000213
2025000011
2025000202
Insider / Designated-Person Trades

7 recent disclosure(s)

Pharmaceutical Business Group [India] LtdDisposal · 30,00,000
Mrs.Avantika Vijay AgarwalAcquisition · 5,400
Mrs.Avantika Vijay AgarwalDisposal · 3,704
Ms. Avantika Vijay AgarwalDisposal · 656
Ms. Avantika Vijay AgarwalDisposal · 9,032
Pharmaceutical Business Group India LimitedAcquisition · 38,50,000
Substantial Acquisitions (SAST)

4 disclosure(s)

Block Trade27/12/2023 · 30,00,000
Off Market / Inter se transfer17/09/2021 · 38,50,000
-17/09/2021 · 38,50,000
Off Market / Inter se transfer17/09/2021 · 38,50,000
Company Information
Incorporated1981
ChairmanDinesh S Patel
AuditorGMJ & Co
Investor Email[email protected]; [email protected]
🌐 www.gtbl.in ↗

📍 69/C GIDC Industrial Estate, Valsad Dist, VAPI, Gujarat, 396195

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

GTPL Hathway LimitedGufic BioSciences Ltd.Gujarat Alkalies & ChemGuj. Apollo Ind. Ltd.Gujarat Gas LimitedGujarat Raffia Indust Ltd.Gulf Oil Lub. Ind. Ltd.GP Petroleums LimitedGulshan Polyols LimitedGurunanak Agricultur In LimitedGVK Pow. & Infra Ltd.GE PowerAll “G” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search